DARA Biosciences Shareholders Equity:
9.638M for Dec. 31, 2012DARA Biosciences Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 9.638M |
| Sept. 30, 2012 | 11.94M |
| June 30, 2012 | 12.55M |
| March 31, 2012 | 4.116M |
| Dec. 31, 2011 | 1.174M |
| Sept. 30, 2011 | 2.343M |
| June 30, 2011 | 3.159M |
| March 31, 2011 | 4.620M |
| Dec. 31, 2010 | 5.106M |
| Sept. 30, 2010 | 0.2728M |
| June 30, 2010 | 1.845M |
| March 31, 2010 | 3.715M |
| Dec. 31, 2009 | 2.723M |
| Sept. 30, 2009 | 2.493M |
| June 30, 2009 | -0.2989M |
| March 31, 2009 | -0.895M |
| Dec. 31, 2008 | 1.704M |
| Sept. 30, 2008 | 1.271M |
| June 30, 2008 | 4.443M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
DARA Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Cyclacel Pharmaceuticals | 10.02M |
| Prana Biotechnology | |
| Bioline Rx | 20.37M |
DARA Shareholders Equity Rankings
| Overall |
42nd percentile 4393 of 7590 |
| Sector |
28th percentile 463 of 651 in Healthcare |
| Industry |
36th percentile 150 of 238 in Biotechnology |
DARA Shareholders Equity Range, Past 5 Years
| Minimum | -0.8950M | Mar 2009 |
| Maximum | 12.55M | Jun 2012 |
| Average | 3.785M |
